Medprin Regenerative Medical Technologies Co., Ltd. Stock
Equities
301033
CNE100004NB8
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
39.5 CNY | -1.64% | +14.49% | -9.28% |
Sales 2024 * | 288M 39.87M | Sales 2025 * | 377M 52.15M | Capitalization | 2.61B 361M |
---|---|---|---|---|---|
Net income 2024 * | 67M 9.27M | Net income 2025 * | 105M 14.53M | EV / Sales 2024 * | 9.06 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 6.93 x |
P/E ratio 2024 * |
38.3
x | P/E ratio 2025 * |
24.8
x | Employees | 278 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 38.47% |
1 day | -1.64% | ||
1 week | +14.49% | ||
Current month | +14.49% | ||
1 month | +25.32% | ||
3 months | +45.33% | ||
6 months | -8.29% | ||
Current year | -9.28% |
Managers | Title | Age | Since |
---|---|---|---|
Yu Yu Yuan
CEO | Chief Executive Officer | 44 | 08-08-31 |
Ya Hong Luo
DFI | Director of Finance/CFO | 56 | 17-01-31 |
Kun Xue Deng
CTO | Chief Tech/Sci/R&D Officer | - | 11-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Xin Lu
BRD | Director/Board Member | 61 | 18-10-31 |
Yu Yu Yuan
CEO | Chief Executive Officer | 44 | 08-08-31 |
Ya Hong Luo
DFI | Director of Finance/CFO | 56 | 17-01-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 39.5 | -1.64% | 1,762,065 |
24-05-09 | 40.16 | -5.51% | 2,221,680 |
24-05-08 | 42.5 | +12.43% | 2,803,601 |
24-05-07 | 37.8 | +4.02% | 1,749,533 |
End-of-day quote Shenzhen S.E., May 09, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-9.28% | 361M | |
+10.39% | 126B | |
-6.86% | 10.96B | |
+2.52% | 8.97B | |
+38.96% | 5.56B | |
-17.50% | 4.99B | |
+8.36% | 3.44B | |
-8.84% | 2.8B | |
-7.52% | 2.18B | |
-3.00% | 2.16B |
- Stock Market
- Equities
- 301033 Stock